Patients with relapsed or refractory multiple myeloma experienced significant indirect social costs from their disease, in addition to the direct costs. (Source: CancerNetwork)
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2oA126K
via IFTTT
Εγγραφή σε:
Σχόλια ανάρτησης (Atom)
Δημοφιλείς αναρτήσεις
-
Papillary squamous cell carcinoma of the palatine tonsil: a rare cancer of the head and neck. Acta Otorhinolaryngol Ital. 2017 May 22;...
-
We present a case of a patient with diabetes with a pleural empyema originated from a pyomyositis process established after a central line p...
-
The New Year is a new start. Embrace the feeling. -- Read more on ScientificAmerican.com from #AlexandrosSfakianakis via Alex...
-
Abstract Kenaf is a multipurpose crop, but a lack of genetic information hinders genetic and molecular research. In this study, we aimed t...
-
Treatment advances have not improved long-term health status of childhood cancer survivors Science Daily Advances in treatment and su...
-
Kalpesh Jayantkumar Gajiwala Indian Journal of Plastic Surgery 2016 49(3):362-369 Background: The skin and soft tissues of the face and ...
-
HER2 gene amplifications and activating mutations in the HER2 receptor tyrosine kinase are present in 4% of metastatic colorectal cancers (...
-
Here are our readers' top 10 favorites from “Plugged In” in 2016 -- Read more on ScientificAmerican.com from #AlexandrosSfaki...
-
Syringocystadenoma papilliferum (SCAP), apocrine gland cyst (AGC, also called apocrine hidrocystoma or apocrine cystadenoma), and tubular pa...
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου